The Berkeley Research Group breaks down the flow of dollars in the pharmaceutical marketplace within the US healthcare system, which involves a variety of stakeholders, rebates, discounts, fees, and other payments. As the study supports, the stakeholders in the supply chain complicate and contribute to ballooning consumer costs.